{"id":"https://openalex.org/W2103201873","doi":"https://doi.org/10.1186/1476-4598-12-19","title":"Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms","display_name":"Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms","alternate_titles":[],"publication_year":2013,"publication_date":"2013-03-07","ids":{"openalex":"https://openalex.org/W2103201873","doi":"https://doi.org/10.1186/1476-4598-12-19","mag":"2103201873","pmid":"https://pubmed.ncbi.nlm.nih.gov/23497317","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3637582"},"language":"en","primary_location":{"id":"doi:10.1186/1476-4598-12-19","doi":"https://doi.org/10.1186/1476-4598-12-19","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1476-4598-12-19","pdf_url":"https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/1476-4598-12-19","source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2103201873"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/1476-4598-12-19","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029393201","display_name":"Kerstin Maria Kampa-Schittenhelm","orcid":"https://orcid.org/0000-0003-0958-5140","observed_orcids":["https://orcid.org/0000-0003-0958-5140"]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kerstin Maria Kampa-Schittenhelm","raw_affiliation_strings":["Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany. kerstin.kampa-schittenhelm@med.uni-tuebingen.de","Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany. kerstin.kampa-schittenhelm@med.uni-tuebingen.de","institution_ids":["https://openalex.org/I4210094118"]},{"raw_affiliation_string":"Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091057405","display_name":"Michael Charles Heinrich","orcid":"https://orcid.org/0000-0003-3790-0478","observed_orcids":["https://orcid.org/0000-0003-3790-0478"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2803065977","display_name":"Portland VA Medical Center","ror":"https://ror.org/02v3txv81","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2803065977","https://openalex.org/I4210144745"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Charles Heinrich","raw_affiliation_strings":["Department of Medicine; Division of Hematology and Medical Oncology, Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, OR, USA","Department of Medicine","Division of Hematology and Medical Oncology, Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine; Division of Hematology and Medical Oncology, Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2803065977","https://openalex.org/I4390039369"]},{"raw_affiliation_string":"Department of Medicine","institution_ids":[]},{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2803065977","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053088911","display_name":"Figen Akmut","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Figen Akmut","raw_affiliation_strings":["Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089395073","display_name":"Hartmut D\u00f6hner","orcid":"https://orcid.org/0000-0003-2116-5536","observed_orcids":["https://orcid.org/0000-0003-2116-5536"]},"institutions":[{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hartmut D\u00f6hner","raw_affiliation_strings":["Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany","institution_ids":["https://openalex.org/I4210155144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053983155","display_name":"Konstanze D\u00f6hner","orcid":"https://orcid.org/0000-0002-2261-9862","observed_orcids":["https://orcid.org/0000-0002-2261-9862"]},"institutions":[{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Konstanze D\u00f6hner","raw_affiliation_strings":["Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany","institution_ids":["https://openalex.org/I4210155144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018040656","display_name":"Marcus Matthias Schittenhelm","orcid":"https://orcid.org/0000-0002-5400-5582","observed_orcids":["https://orcid.org/0000-0002-5400-5582"]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcus Matthias Schittenhelm","raw_affiliation_strings":["Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5029393201"],"corresponding_institution_ids":["https://openalex.org/I4210094118"],"apc_list":{"value":5090,"currency":"USD","value_usd":5090},"apc_paid":{"value":5090,"currency":"USD","value_usd":5090},"fwci":7.0483,"has_fulltext":true,"cited_by_count":131,"citation_normalized_percentile":{"value":0.97514241,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"12","issue":"1","first_page":"19","last_page":"19"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.012600000016391277,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quizartinib","display_name":"quizartinib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ac220","display_name":"AC220","score":0.8889999985694885},{"id":"https://openalex.org/keywords/flt3","display_name":"FLT3","score":0.5210000276565552},{"id":"https://openalex.org/keywords/pdgfra","display_name":"PDGFRA","score":0.7940000295639038},{"id":"https://openalex.org/keywords/kit","display_name":"KIT","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.847000002861023},{"id":"https://openalex.org/keywords/flt3-itd-acute-myeloid-leukemia","display_name":"FLT3-ITD acute myeloid leukemia","score":0.8619999885559082},{"id":"https://openalex.org/keywords/kit-d816v-mutation","display_name":"KIT D816V mutation","score":0.8109999895095825},{"id":"https://openalex.org/keywords/kinase-inhibitor-resistance","display_name":"kinase inhibitor resistance","score":0.5299999713897705},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6669999957084656},{"id":"https://openalex.org/keywords/mutation-detection","display_name":"mutation detection","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5968106985092163},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.577344536781311},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5660960674285889},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5562915205955505},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5071189403533936},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4691157639026642},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4378446340560913},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41639867424964905},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26721319556236267},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.22446012496948242},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15218377113342285},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1464361846446991},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10895371437072754},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07066279649734497}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019009","descriptor_name":"Proto-Oncogene Proteins c-kit","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019009","descriptor_name":"Proto-Oncogene Proteins c-kit","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019009","descriptor_name":"Proto-Oncogene Proteins c-kit","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020796","descriptor_name":"Receptor, Platelet-Derived Growth Factor alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020796","descriptor_name":"Receptor, Platelet-Derived Growth Factor alpha","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020796","descriptor_name":"Receptor, Platelet-Derived Growth Factor alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046152","descriptor_name":"Gastrointestinal Stromal Tumors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D046152","descriptor_name":"Gastrointestinal Stromal Tumors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051941","descriptor_name":"fms-Like Tyrosine Kinase 3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051941","descriptor_name":"fms-Like Tyrosine Kinase 3","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051941","descriptor_name":"fms-Like Tyrosine Kinase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D052160","descriptor_name":"Benzothiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1186/1476-4598-12-19","doi":"https://doi.org/10.1186/1476-4598-12-19","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1476-4598-12-19","pdf_url":"https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/1476-4598-12-19","source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2633133","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3637582","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3637582","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3637582/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Cancer","raw_type":"Text"},{"id":"pmid:23497317","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23497317","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.689.2230","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.689.2230","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.heinrich-corless.net/1476-4598-12-19.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1186/1476-4598-12-19","doi":"https://doi.org/10.1186/1476-4598-12-19","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1476-4598-12-19","pdf_url":"https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/1476-4598-12-19","source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2103201873.pdf","grobid_xml":"https://content.openalex.org/works/W2103201873.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W11751756","https://openalex.org/W107845490","https://openalex.org/W1507654024","https://openalex.org/W1592701464","https://openalex.org/W1971056717","https://openalex.org/W1974674483","https://openalex.org/W1979476401","https://openalex.org/W1984209370","https://openalex.org/W1985872661","https://openalex.org/W1988614680","https://openalex.org/W1990992718","https://openalex.org/W1995664066","https://openalex.org/W1996885535","https://openalex.org/W2002927399","https://openalex.org/W2011187792","https://openalex.org/W2012952884","https://openalex.org/W2016883830","https://openalex.org/W2020426326","https://openalex.org/W2036144994","https://openalex.org/W2041567295","https://openalex.org/W2048369203","https://openalex.org/W2069232534","https://openalex.org/W2069578188","https://openalex.org/W2079094777","https://openalex.org/W2079420659","https://openalex.org/W2084855648","https://openalex.org/W2099200814","https://openalex.org/W2101214437","https://openalex.org/W2101886636","https://openalex.org/W2109331088","https://openalex.org/W2110828128","https://openalex.org/W2111914345","https://openalex.org/W2116768113","https://openalex.org/W2116978122","https://openalex.org/W2118781121","https://openalex.org/W2122205781","https://openalex.org/W2127933711","https://openalex.org/W2130864403","https://openalex.org/W2134094496","https://openalex.org/W2135057615","https://openalex.org/W2135429827","https://openalex.org/W2139836387","https://openalex.org/W2146597025","https://openalex.org/W2152262856","https://openalex.org/W2154625299","https://openalex.org/W2164886552","https://openalex.org/W2165392081","https://openalex.org/W2165720262","https://openalex.org/W2169076372","https://openalex.org/W2171484579","https://openalex.org/W2309813814","https://openalex.org/W2313413337","https://openalex.org/W2620070077"],"related_works":["https://openalex.org/W4248689503","https://openalex.org/W2979348556","https://openalex.org/W2951343996","https://openalex.org/W2611389607","https://openalex.org/W2976062932","https://openalex.org/W2954016812","https://openalex.org/W4405048305","https://openalex.org/W2954293927","https://openalex.org/W2146265383"],"abstract_inverted_index":{"BACKGROUND:":[0],"Activating":[1],"mutations":[2],"of":[3,36,60,68,160,191,195,204,217,222,269,315],"class":[4,136,307],"III":[5,137,308],"receptor":[6,309],"tyrosine":[7,44],"kinases":[8],"(RTK)":[9],"FLT3,":[10,131,180],"PDGFR":[11,207],"and":[12,34,40,64,88,105,148,157,208,220,263],"KIT":[13,144,181,197,264],"are":[14,48],"associated":[15],"with":[16,102,251,280,295],"multiple":[17],"human":[18],"neoplasms":[19,32],"including":[20],"hematologic":[21],"malignancies,":[22],"for":[23,79,115],"example:":[24],"systemic":[25],"mast":[26],"cell":[27,146,176],"disorders":[28],"(KIT),":[29],"non-CML":[30],"myeloproliferative":[31],"(PDGFR)":[33],"subsets":[35],"acute":[37],"leukemias":[38],"(FLT3":[39],"KIT).":[41],"First":[42],"generation":[43,82],"kinase":[45,123,169,292],"inhibitors":[46],"(TKI)":[47],"rapidly":[49],"being":[50,254],"integrated":[51],"into":[52],"routine":[53],"cancer":[54],"care.":[55],"However,":[56,239],"the":[57,65,77,155,167,189,240,247,281,296],"expanding":[58],"spectrum":[59,314],"TK-mutations,":[61],"bioavailability":[62],"issues":[63],"emerging":[66],"problem":[67],"primary":[69],"or":[70,143,182,198],"secondary":[71],"TKI-therapy":[72],"resistance":[73],"have":[74,125],"lead":[75],"to":[76,84,89,96,130,153,214,257,299,322],"search":[78],"novel":[80],"second":[81],"TKIs":[83],"improve":[85],"target":[86],"potency":[87],"overcome":[90],"resistant":[91],"clones.Quizartinib":[92],"was":[93],"recently":[94],"demonstrated":[95],"be":[97],"a":[98,111,277,304],"selective":[99],"FLT3":[100,116,142,199,209,261],"inhibitor":[101],"excellent":[103],"pharmacokinetics":[104],"promising":[106],"in":[107,110,128,224,225,232,271],"vivo":[108],"activity":[109,316],"phase":[112],"II":[113],"study":[114],"ITD":[117],"+":[118],"AML":[119],"patients.":[120],"In":[121],"vitro":[122,226],"assays":[124],"suggested":[126],"that":[127],"addition":[129],"quizartinib":[132,192,212],"also":[133],"targets":[134],"related":[135],"RTK":[138],"isoforms.":[139,184,200],"METHODS:":[140],"Various":[141],"leukemia":[145,227,234],"lines":[147],"native":[149,233],"blasts":[150,235],"were":[151],"used":[152],"determine":[154],"antiproliferative":[156],"proapoptotic":[158],"efficacy":[159],"quizartinib.":[161,300],"To":[162],"better":[163],"compare":[164],"differences":[165],"between":[166],"mutant":[168,196],"isoforms,":[170],"we":[171,187],"generated":[172],"an":[173,272],"isogenic":[174,273],"BaF3":[175],"line":[177],"expressing":[178],"different":[179],"BCR/ABL":[183],"Using":[185],"immunoblotting,":[186],"examined":[188],"effects":[190],"on":[193,246],"activation":[194],"RESULTS:":[201],"Kinase":[202],"inhibition":[203,216,293],"(mutant)":[205],"KIT,":[206],"isoforms":[210,253],"by":[211,288],"leads":[213],"potent":[215,305],"cellular":[218,274,297],"proliferation":[219],"induction":[221],"apoptosis":[223],"models":[228],"as":[229,231],"well":[230],"treated":[236],"ex":[237],"vivo.":[238],"sensitivity":[241],"patterns":[242],"vary":[243],"widely":[244],"depending":[245],"underlying":[248,282],"(mutant)-kinase":[249],"isoform,":[250],"some":[252],"relatively":[255],"insensitive":[256],"this":[258],"agent":[259],"(e.g.":[260],"D835V":[262],"codon":[265],"D816":[266],"mutations).":[267],"Evaluation":[268],"sensitivities":[270],"background":[275],"confirms":[276],"direct":[278],"association":[279],"mutant-TK":[283],"isoform--which":[284],"is":[285,303],"further":[286],"validated":[287],"immunoblotting":[289],"experiments":[290],"demonstrating":[291],"consistent":[294],"sensitivity/resistance":[298],"CONCLUSION:":[301],"Quizartinib":[302],"second-generation":[306],"TK-inhibitor--but":[310],"specific,":[311],"mutation":[312,319],"restricted":[313],"may":[317],"require":[318],"screening":[320],"prior":[321],"therapy.":[323]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2103201873","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
